Viewing Study NCT01223066


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-27 @ 9:52 PM
Study NCT ID: NCT01223066
Status: WITHDRAWN
Last Update Posted: 2022-08-25
First Post: 2010-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Macrolane Prospective Survey
Sponsor: Galderma R&D
Organization:

Study Overview

Official Title: A Multi-center, Non-interventional, Prospective Study to Monitor Long Term Safety in Female Subjects After Treatment With Macrolane Volume Restoration Factor 20 and/or Macrolane Volume Restoration Factor 30 in the Breasts.
Status: WITHDRAWN
Status Verified Date: 2012-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: no patients recruited
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study objective is to evaluate the long term safety when Macrolane Volume Restoration Factor is used in female breasts in clinical practice.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: